At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Aug 11, 2026 at 17:15 ET
A cluster of insider selling at Dianthus Therapeutics (DNTH) totaling $2.99M over a 7-day window, led by the CEO ($1.12M) and General Counsel ($1.78M). The selling is concentrated at prices near $107-$111, representing ~0.05% of the $6.1B market cap, which is below the 0.1% materiality threshold. While C-suite participation adds weight, the absolute dollar amount is trivial relative to market cap, and the selling is likely liquidity-driven following option exercises rather than a bearish signal.
- Total insider selling of $2.99M over 7 days, representing ~0.05% of $6.1B market cap
- CEO Marino Garcia sold $1.12M (10.4K shares at $107.49) on 2026-08-07
- General Counsel Adam Veness sold $1.78M (16.2K shares at $110.38) on 2026-08-10
- All sales are open-market; several insiders also exercised options at low strike prices ($0-$19.36) on same day
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access